One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful ...

A woman whose mother, aunt and grandmother died from Huntington's disease has described a breakthrough in treating the ...

UniQure stock crashed Monday on "confusing" and "unexpected" feedback from the FDA for its Huntington's disease gene therapy.

Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game-changer. | FDA is said to be making a U-turn on ...

LEXINGTON, Mass. and AMSTERDAM, Nov. 03, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing ...

An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

An experimental gene therapy seems to show potential to slow the debilitating progression of Huntington's disease, a European ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

MRI of a brain with Huntington's Disease. Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University ...

However, in late September 2025, scientists successfully treated Huntington’s for the first time in a ground-breaking study.

Nearly 150 people gathered at Waterfront Park on Sunday for the Huntington’s Disease Society of America’s Team Hope Walk, uniting families, advocates and supporters. IMPORTANCE. ACCORDING TO THE ...